Latest Analgesics Stories

Voluntary Product Recall Initiated by Qualitest Pharmaceuticals Impacts Three Lots of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg Repackaged and Distributed by Mylan Institutional

2012-12-20 08:26:34

PITTSBURGH, Dec. 20, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its Mylan Institutional business is conducting a voluntary nationwide recall to the retail level of three lots of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg (Lots 3037841, 3040859 and 3042573). The three lots were manufactured by Qualitest Pharmaceuticals, and Mylan Institutional repackaged and distributed the product in unit dose (CD100) under the UDL Laboratories, Inc....

Cadence Pharmaceuticals Announces Termination of Option Agreement to Acquire Incline Therapeutics, Inc.

2012-12-12 08:27:23

SAN DIEGO, Calif., Dec. 12, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced today that it has entered into an agreement to terminate its exclusive option to acquire privately-held Incline Therapeutics, Inc., or Incline. Under the waiver, consent and option termination agreement signed by Cadence...

Qualitest Issues Voluntary, Nationwide Recall of 101 Lots of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg Due to the Potential for Oversized Tablets

2012-12-06 20:22:11

HUNTSVILLE, Ala., Dec. 6, 2012 /PRNewswire/ -- Qualitest, a subsidiary of Endo Health Solutions, (Nasdaq: ENDP) today issued a voluntary nationwide recall for 101 lots of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg. This includes product with the following NDC numbers and lot numbers beginning with the letter "C". NDC Number Bottle Count ---------- ------------ 0603-3888-16 30...

Cadence Pharmaceuticals to Host Analyst and Investor Day

2012-11-28 16:25:37

SAN DIEGO, Nov. 28, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today announced that the company will host an Analyst and Investor Day for financial analysts on Thursday, December 6, 2012, from 9:00 am to 12:00 pm EST in New York, NY. Members of the Cadence senior management team will provide an update...

Cadence Pharmaceuticals Announces Settlement of OFIRMEV® (Acetaminophen) Injection Patent Litigation with Perrigo Company

2012-11-28 08:28:58

SAN DIEGO, Nov. 28, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX) today announced that it has entered into settlement and license agreements with Perrigo Company (Nasdaq: PRGO; TASE), and its subsidiary, Paddock Laboratories, LLC, to resolve pending patent litigation involving OFIRMEV® (acetaminophen) injection. The settlement agreement includes a stipulation by the parties requesting dismissal with prejudice of the lawsuit filed by Cadence in the U.S. District...

Actress Ashley LeConte Campbell Named Spokesperson for AminoActiv®

2012-11-27 08:24:36

MADISON, Tenn., Nov. 27, 2012 /PRNewswire/ -- She has appeared on the big screen in films such as The Blind Side and Scary Movie 5. Her numerous television credits include a recurring role on "Drop Dead Diva," and co-starring roles in "Army Wives," "The Gates," and "The Game." But now, actress Ashley LeConte Campbell is undertaking a new role: She is the official spokesperson of AminoActiv®, the natural, non-toxic anti-inflammatory pain reliever consumers are increasingly choosing...

Acetaminophen May Raise Infant Asthma Risk

Acetaminophen Could Raise Asthma Risk In Infants, Study Concludes

2012-11-14 20:17:31

Lee Rannals for redOrbit.com – Your Universe Online Findings reported in the Journal of Allergy and Clinical Immunology showed babies that were given acetaminophen for pain and fever may have an increased risk of asthma symptoms. The Danish study included 336 children who were followed from birth to age seven. All of the children's mothers in the study had asthma, putting them at an increased risk for developing the lung disease. During the study, the children were assessed for...

What Patients Need to Know about Acetaminophen

2012-11-12 08:28:15

BOSTON, Nov. 12, 2012 /PRNewswire/ -- The misuse of acetaminophen is the leading cause of acute liver failure in the West. Informed patients and clearly labeled prescription bottles are necessary to avoid accidental overdoses. Patients with new prescriptions often are unaware of the presence of acetaminophen in their new drug nor do they recall their prescribers' advice concerning acetaminophen, according to researchers at Northwestern University who examined the behavior of 249...

The Link between Acute Liver Failure and Bariatric Surgery

2012-11-10 08:21:32

BOSTON, Nov. 10, 2012 /PRNewswire/ -- Among patients with acetaminophen-induced acute liver failure (ALF), bariatric surgery was 25 times more common than in the general population. Researchers at California Pacific Medical Center (CPMC) reported an alarming rate of bariatric surgery among patients with ALF from acetaminophen poisoning. They studied 101 patients with ALF between 2009 and 2011, of whom 54 had acetaminophen-induced ALF. Of those 54 patients 9 - or 16.7...

Jazz Pharmaceuticals Announces Participation In Three Investor Conferences In November

2012-11-09 20:22:10

DUBLIN, Nov. 9, 2012 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that the company will participate in three upcoming investor conferences. A live webcast of each presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. The conferences and presentation times include: Lazard Capital Markets 9(th) Annual Healthcare Conference in New York, NY on Wednesday, November 14, 2012 at 8:00 a.m....